Platelets-Rich Plasma Market: By Type; By Source; By Growth Factor Molecule; By Application; By Geography - Forecast 2016-2021

  • ID: 4532463
  • Report
  • Region: Global
  • 155 pages
  • IndustryARC
1 of 4

FEATURED COMPANIES

  • AdiStem Ltd.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc.
  • Dr. PRP America LLC
  • MORE
Platelet-rich plasma (PRP) is an autologous product that distillates a huge quantity of platelets in a small volume of plasma. It has a platelet concentration above the baseline. Owing to its high usage in wound healing, platelet-rich plasma (PRP) has spanned its utility in various fields of dermatology from chronic ulcer management to trichology and aesthetics. At present, platelet-rich plasma (PRP) is extensively used in numerous clinical scenarios like orthopedics, ophthalmology and healing therapies, as a growth factor pool for enhancing tissue regeneration. The chief purpose of platelets are to avert severe blood loss and repairing vascular walls and adjacent tissues after injury. PRP is injected into the tissue or joint that is considered to be the pain initiator.

Platelets-Rich Plasma are widely used in medical applications, especially in surgeries and have benign function like it is being used for neurosurgery, cosmetic surgery and more. Major Platelets-Rich Plasma that are used in humans quickens endothelial, epithelial, and epidermal rejuvenation, arouses angiogenesis, augments collagen synthesis, promotes soft tissue healing, enhances the hemostatic response to injury and many more. Moreover, Platelets-Rich Plasma do reduce the dermal scarring as well. The materials are highly useful to heal damaged tissue and advance body functions.

The increasing consideration towards the safety of human health as well as increased funds & grants by government bodies worldwide, have further resulted in more consumption of platelets-Rich plasma in numerous surgery applications as well as regions. Major types of platelets-rich plasma commercially available are leukocyte-rich PRP, pure PRP, PRP gel, pure platelet-rich fibrin and others. The report also focuses on different geographic regions and the key countries in terms of changing trends in Platelets-Rich Plasma market in various fields.

Platelets-rich plasma are extensively used in surgery applications. They majorly find their use in applications such as orthopedic, surgery, cosmetic surgery, general surgery, neurosurgery and more. In neurosurgery, PRP is specifically used pituitary tumor removal, skull base tumor resection resection, acoustic neuroma excisions and others. Furthermore, it is also used in numerous orthopedic surgeries such as total hip replacement, total knee replacement, scoliosis repair and many more.

The end user industry is the major driver for the platelets-rich plasma market to grow. Platelets-rich plasma find their applications in various segments of medical applications like neurosurgery, cosmetic surgery, orthopedic/spinal surgery, cardiothoracic surgery, general surgery and more. The extensive number of cosmetic surgeries performed is considered as one of the most prominent factor propelling the growth of the global PRP market. However, some factors that restrict the growth of global PRP market include high cost of the devices and therapy as well as threat of therapy failure.

North America dominated the global platelets-rich plasma market. The platelets-rich plasma based research, growing demand in cosmetic surgery in U.S. is all set to drive the demand of platelets-rich plasma materials in North America region. Major players involved in this market are mainly concentrating on R&D initiatives and new product developments to cater the needs of customers. Moreover, booming medical & healthcare industry will directly impact the demand of the platelets-rich plasma over the foreseeable period.

The dominance of North America region was primarily because of growing occurrence of orthopedic diseases, increasing cosmetic surgeries, sanctions of various devices by the U.S. FDA as well as rising consciousness among the patient population. APAC, especially Japan is the fastest growing markets for platelets-rich plasma as it is a world leader in medical surgeries. Additionally, medical tourism is yet another factor that is propelling the growth of PRP in this region. Countries that will experience strong growth include China, Vietnam, India, China, Sri Lanka, Myanmar and Bangladesh. In the recent years, with increasing emphasis on health safety and reducing, end-product manufacturers have preferred this material.

The global platelets-rich plasma market is evaluated based on key attributes such as types, source, application, growth factor molecules and others. Each of the segmentations in the report has been studied to give comprehensive analysis of global platelets-rich plasma market. The overall market has also been consolidated from the perspective of different geographic locations into standard geographic regions and key economies for this market. Additionally, this report encompasses opportunity analysis, porter analysis, pricing analysis and market forces such as drivers, constraints and challenges that are involved to drive the overall market.

Sample companies profiled in this report are:
Arthrex, Inc.,
Biomet, Inc.,
AdiStem Ltd.,
EmCyte Corporation
10+
This report gives detailed information about the product value chain right from the beginning which includes raw materials till end-use. The market is analyzed based on the key attributes such as the power in the hands of producers and consumers, analysis on the degree of competition, and threats from substitutes and new entrants. The study includes the demand of this particular market on a global and regional scale for a six year period of 2016-2021, both in terms of volume(kilo tons) and revenue($ million).
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AdiStem Ltd.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc.
  • Dr. PRP America LLC
  • MORE

1. MARKET OVERVIEW

2. EXECUTIVE SUMMARY

3. PLATELETS-RICH PLASMA MARKET - LANDSCAPE
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Top 5 Financials Analysis

4. PLATELETS-RICH PLASMA MARKET FORCES
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Market Attractiveness
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Rivalry Among the Competitors

5. PLATELETS-RICH PLASMA - STRATEGIC ANALYSIS
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Supplier & Distributors
5.5. Market Life Cycle Analysis

6. PLATELETS-RICH PLASMA MARKET – BY TYPE
6.1. Leukocyte-Rich PRP
6.2. Pure PRP
6.3. PRP Gel
6.4. Pure Platelet-Rich Fibrin
6.5. Others

7. PLATELETS-RICH PLASMA MARKET – BY SOURCE
7.1. Homologus PRP
7.2. Autologus PRP
7.3. Allogenic PRP
7.4. Others

8. PLATELETS-RICH PLASMA MARKET – BY APPLICATION
8.1. General Surgery
8.2. Neurosurgery
8.3. Cosmetic Surgery
8.4. Periodontal Surgery
8.5. Orthopedic/Spinal Surgery
8.6. Cardiothoracic Surgery
8.7. Others

9. PLATELETS-RICH PLASMA MARKET - BY GROWTH FACTOR MOLECULES
9.1. Platelet-derived growth factor (PDGF)
9.2. Vascular endothelial growth factor (VEGF)
9.3. Epidermal growth factor (EGF)
9.4. Fibroblast growth factor-2 (FGF-2)
9.5. Insulin-like growth factor (IGF)
9.6. Others

10. PLATELETS-RICH PLASMA MARKET – BY GEOGRAPHY
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.1.3. Mexico
10.1.4. Others
10.2. Europe
10.2.1. Germany
10.2.2. U.K.
10.2.3. France
10.2.4. Others
10.3. APAC
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Others
10.4. RoW

11. MARKET ENTROPY
11.1. New Product Launches
11.2. M&A’s, Collaborations, JVs And Partnerships
12. APPENDIX
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer

13. PLATELETS-RICH PLASMA MARKET - COMPANY PROFILES
13.1. Arthrex, Inc.
13.2. AdiStem Ltd.
13.3. Arteriocyte Medical Systems, Inc.
13.4. Biomet, Inc.
13.5. Cesca Therapeutics, Inc.
13.6. DePuy Synthes, Inc.
13.7. EmCyte Corporation
13.8. Dr. PRP America LLC
13.9. Exactech, Inc.
13.10. Harvest Technologies Corp.
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • AdiStem Ltd.
  • Arteriocyte Medical Systems, Inc.
  • Arthrex, Inc.
  • Biomet, Inc.
  • Cesca Therapeutics, Inc.
  • DePuy Synthes, Inc.
  • Dr. PRP America LLC
  • EmCyte Corporation
  • Exactech, Inc.
  • Harvest Technologies Corp.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll